have demonstrated the involvement of BMP in both structure and function of late endosomes/lysosomes. 4 We and others have underlined the role of BMP in cellular cholesterol transport and distribution. It was first reported that treatment of cultured fibroblasts with anti-BMP antibody that accumulates in late endosomes resulted in a massive accumulation of cholesterol in this compartment. 3, 5 The modulation of BMP domains by the glycolipid inhibitor d-threo-1-phenyl-2-decanoylamino-3-morpholino-1-propanol altered cellular cholesterol homeostasis in these cells. 6 More recently, it was demonstrated that cholesterol exit and retention in late endosomes depend on BMP content in this compartment, through a mechanism involving the endosomal protein Alix. 7 Our studies in both murine and human macrophages showed that endosomal accumulation of anti-BMP antibody altered cholesterol distribution in relation to reduced cholesterol efflux to HDL. 8 Most human and animal cells or tissues contain relatively low amounts of BMP, not exceeding 1% to 2% of total phospholipids. However, the level of BMP was shown to dramatically increase in certain inherited lysosomal storage disorders, a group of diseases characterized by endolysosomal lipidosis, such as Niemann-Pick (NP) and Gaucher diseases. 4 Gaucher disease, that displays lipid-engorged cells of the monocytemacrophage lineage, has been associated with low HDL cholesterol concentration, evocating a deregulation of cholesterol homeostasis. 9 Furthermore, BMP accumulation has been recently reported as a noticeable feature of oxidized LDL (oxLDL)-laden macrophages. 10 To date, literature dealing with the understanding of cholesterol-related functions of BMP is rather scarce. We have previously reported that cellular BMP content was significantly increased after incubation of RAW 264.7 macrophages with the precursor dioleoyl-phosphatidylglycerol (18:1/18:1-PG). 11 This approach was considered as a valuable model of BMP accumulation regarding that BMP produced from exogenous PG by RAW macrophages has been shown to keep the unique sn1:sn1′ stereoconfiguration of natural BMP. 12 In addition, we here report that 18:1/18:1-BMP was primarily increased after supplementation with 18:1/18:1-PG, thus mimicking the conditions found in lysosomal storage disorder for both cellular and plasma BMP accumulation. 13 Our results show for the first time that endosomal BMP accumulation impacts on cholesterol distribution and efflux in association with changes in cholesterol-regulating genes. Molecular mechanisms involving liver-X receptor (LXR)/ABCA1/ABCG1 are proposed to contribute to the effects of BMP on cholesterol homeostasis and, especially, efflux in macrophages.
Materials and Methods
Materials and Methods are available in the online-only Supplement.
Results

Supplementation With 18:1/18:1-PG Induced the Specific Accumulation of BMP in Late Endosomes
We previously reported that supplementation of cultured RAW macrophages with 30 µmol/L of 18:1/18:1-PG liposomes induced cellular accumulation of BMP with no change in other phospholipase, namely phosphatidylcholine and phosphatidylethanolamine. 11 Here, we further show that PG content did not change in this condition, whereas BMP content was increased 2-fold ( Figure 1A ). The conversion of PG to BMP in RAW macrophages requires a PG-selective phospholipase A 2 , whose activity toward 16:0/16:0-PG is low compared with oleate-containing PG. 14 Consistently, we found that BMP content was unchanged in cells supplemented with 30 µmol/L of 16:0/16:0-PG, whereas PG content was significantly increased. Total PG plus BMP reached similar amounts in both 16:0/16:0-PG-and 18:1/18:1-PG-supplemented cells, about twice that in controls (7333, 7889, and 3799 pmol/mg protein for the 2 added PG and control samples, respectively), indicating that both PG were taken by the cells at equal rate, with no conversion of 16:0/16:0-PG and total conversion of 18:1/18:1-PG to BMP. As shown in Table 1 , 18:1/18:1-BMP was the major BMP molecular species in 18:1/18:1-PG-supplemented cells. Overall, molecular species composition of BMP in these cells was similar to control cells. Supplementation with 16:0/16:0-PG resulted in a large increase in 16:0/16:0-PG at the expense of other PG molecular species (Table 2) , which confirms previous reports indicating that 16 :0/16:0-PG was not metabolized in RAW macrophages. The intracellular distribution of BMP was visualized with the anti-BMP antibody (6C4; Figure 1B ). The endosomal localization of BMP in control RAW macrophages is supported by the colocalization with tetrapanin CD63, a late endosome marker. BMP immunofluorescence in 18:1/18:1-PG-supplemented cells revealed a punctuated and perinuclear staining similar to control cells and colocalized with CD63, supporting an endosomal location of newly synthesized BMP. Supplementation with 18:1/18:1-PG liposomes was then used as a model of specific endosomal BMP accumulation, as referred to BMP-enriched cells, in the next experiments.
A B
BMP Accumulation Does Not Modify LDL-Derived Cholesterol Delivery to Macrophages
Free cholesterol (FC) delivery to macrophages after LDL endocytosis depends on LDL uptake, hydrolysis of LDLassociated cholesteryl esters (CE) in the late endosomal/ lysosomal compartment, and cholesterol re-esterification in the ER by acetyl-coenzyme A acetyltransferase. No difference in LDL uptake, as assessed using [ 3 H]cholesteryl oleate-LDL, was observed between control and BMP-enriched cells (Figure 2A ). Hydrolysis of LDL-associated CE was measured in the presence of 2 µg/mL acetyl-coenzyme A acetyltransferase inhibitor F1394 to avoid cholesterol re-esterification. At this concentration, F1394 led to complete inhibition of cholesterol esterification as assayed by [ 3 H]oleate incorporation test (not shown). Figure 2B indicates similar rate of CE hydrolysis in both control and BMP-enriched cells. Cholesterol esterification was measured as the proportion of radioactivity recovered in CE after incubation with [ 3 H]cholesterol-LDL or [ 3 H] cholesterol. Under all tested conditions, no difference was observed between control and BMP-enriched cells ( Figure  2C ). These data suggest no change in the esterification process after BMP accumulation.
Cellular levels of FC and CE were also quantified ( Figure 2D ). Under basal conditions (unloaded), FC content was slightly increased (≈10%; P≤0.05) in BMP-enriched cells compared with controls. After loading with LDL, FC content was increased by ≈40% compared with basal conditions, and no effect of BMP accumulation could be observed. CE contents were similar in control and BMP-enriched cells under basal conditions and were equally increased (≈3-fold) after loading with LDL. These data indicate no or only minor change in cellular FC and CE contents in BMP-enriched cells, at least at the whole cell level. Altogether, these results indicate that BMP accumulation neither alters LDL internalization and hydrolysis nor subsequent cholesterol re-esterification.
BMP Accumulation Is Associated With Redistribution of LDL-Derived Cholesterol
The consequences of BMP accumulation on LDL-derived cholesterol transport to PM and ER were examined. We previously showed that cholesterol efflux to methyl-β-cyclodextrin is indicative of the proportion of LDL-derived cholesterol transported to the PM in RAW macrophages. 8 As shown in Figure 3A , cholesterol efflux to methyl-β-cyclodextrin was significantly reduced in BMP-enriched cells compared with controls (≈−20%; P≤0.05), suggesting a decreased transport of cholesterol to PM.
The content of cholesterol in ER is known to regulate the expression of sterol regulatory element-binding protein (SREBP) 2 and SREBP2 target genes, such as hydroxymethylglutaryl-coenzyme A reductase. 15 As expected, cell loading with LDL, which is assumed to increase ER cholesterol, significantly decreased SREBP2 mRNA level (≈−40% versus controls; P=0.0016; Figure 3B ). Treatment with U18666A (1 µg/mL), which has been reported to inhibit cholesterol transport to ER in many cells, including RAW macrophages, 8, 16 consistently reversed LDL-induced suppression of SREBP2 and increased SREBP2 expression above control values (1.4fold versus controls; P=0.024). Conversely, LDL-induced suppression of SREBP2 was exacerbated in BMP-enriched cells (≈−80% versus control; P<0.0001 and ≈−60% versus LDL; P=0.0014). Similar variations were observed for hydroxymethylglutaryl-coenzyme A reductase mRNA ( Figure 3C ). These results suggest that BMP accumulation is associated with an increase in ER cholesterol.
BMP Accumulation Decreased HDL-and ApoA1-Stimulated Cholesterol Efflux
Macrophages were then challenged for their capacity to release cholesterol in response to HDL and apoA1 after cell loading with LDL. As shown in Figure 4A , both HDL-and apoA1stimulated efflux were reduced by ≈40% in BMP-enriched cells compared with controls (P<0.0005 and P<0.001, respectively). Significant diminution of HDL-stimulated cholesterol efflux could be observed throughout time-course experiments ( Figure 4B ). As control for BMP specificity, cholesterol efflux to HDL was measured in PG-enriched cells (supplemented with 16:0/16:0-PG), and no difference was observed with controls (20.7±2.3 versus 22.3±2.2%, respectively; mean±SD of 3 determinations).
Data from methyl-β-cyclodextrin-mediated cholesterol efflux ( Figure 3A ) suggest that the transport of LDL-derived cholesterol to PM is decreased in BMP-enriched cells, which could explain the lower cholesterol efflux in LDL-loaded cells. In another series of experiments, cells were incubated with free [ 3 H]cholesterol that can exchange with PM and label cellular pools independent of LDL loading. A decrease in cholesterol efflux to HDL and apoA1 was then observed in BMP-enriched cells compared with controls (HDL: −52%; P<0.0005; apoA1: −46%; P<0.05; Figure 4C ). Altogether, these results suggest that the decrease in LDL-derived cholesterol efflux in BMP-enriched cells did not result from lower cholesterol availability in PM.
Decreased Expression of ABCA1 and ABCG1 Transporters and LXR Receptors Is Involved in Decreased Cholesterol Efflux in BMP-Enriched Cells
HDL and apoA1-stimulated efflux of cholesterol in macrophages have been shown to essentially depend on the expression/activity of ABC transporters G1 and A1, respectively. 17, 18 As shown in Figure 5A and 5B, loading with LDL increased ABCA1 and ABCG1 mRNA levels, by 4-and 2-fold, respectively, versus controls (P<0.0001). These results are per se important because previous studies have only reported induced expression of ABCA1 and ABCG1 in murine macrophages on loading with acetylated/oxLDL. 19, 20 Our present data, therefore, indicate that exposure to native LDL alone is sufficient to increase expression of both ABCA1 and ABCG1, although to a lower extent compared with modified LDL. Noteworthy, ABCA1 expression was significantly reduced in BMP-enriched cells under both basal conditions (18:1/18:1-PG versus controls, −70%; P=0.038) and after LDL loading (LDL+18:1/18:1-PG versus LDL, −70%; P<0.0001; Figure  5A ). Similar effects were obtained for ABCG1 (18:1/18:1-PG versus controls, −47%; P=0.012 and LDL+18:1/18:1-PG versus LDL, −49%; P<0.0001; Figure 5B ). The decrease in basal expression of these transporters may explain the decrease in cholesterol efflux observed in cells labeled with [ 3 H]FC ( Figure 4C ). As control for BMP specificity, ABCG1 expression was measured in PG-enriched cells (supplemented with 16:0/16:0-PG), and no significant difference was observed versus controls (85.0±17.3 versus 85.8±7.2, relative values, mean±SD of 3 determinations), which is consistent with unchanged cholesterol efflux to HDL in these cells. Altogether, these data indicate that lower cholesterol efflux to HDL and apoA1 could result from the decreased expression of ABCA1 and G1 transporters.
Because ABCA1 and ABCG1 are target genes of LXR α and β in RAW macrophages, 19, 20 we also studied the putative involvement of LXRs in the decrease of cholesterol efflux in BMP-enriched cells. To evaluate the role of LXR activators, cells were treated with the LXR ligand 22(R)hydroxy-cholesterol (22(R)) in association with retinoic acid, resulting in the induction of both ABCA1 and ABCG1 genes (not shown). As illustrated in Figure 5C , LXR activation triggered significant apoA1-mediated cholesterol efflux and enhanced HDLmediated efflux (50% versus 25% in control nontreated cells; cf Figure 4A ). Under these conditions, cholesterol efflux was similar in both control and BMP-enriched cells, indicating that 22(R)/retinoic acid was able to reverse the effects of BMP accumulation. The expression of LXRs was also examined ( Figure  5D and 5E). As previously reported, 19, 20 LXRβ is more highly expressed than LXRα in RAW macrophages. Loading with LDL increased both LXRα (1.3-fold; P=0.0012) and LXRβ (1.4-fold; P=0.016) mRNA levels. LXRα expression was significantly reduced in BMP-enriched cells on LDL loading (LDL+18:1/18:1-PG versus LDL, −50%; P<0.0001) and under basal conditions, although to a lower extent (18:1/18:1-PG versus controls, −22%; P=0.0014; Figure 5D ). Similar effects were obtained for LXRβ (LDL+18:1/18:1-PG versus LDL, −65%; P<0.0001 and 18:1/18:1-PG versus controls, −29%; P=0.045; Figure 5E ). These effects paralleled those observed for ABCA1 and ABCG1, suggesting that a downregulation of LXRs could participate in downregulating these ABC transporters. Again, no difference was observed in PG-enriched cells (supplemented with 16:0/16:0-PG) versus controls (LXRα, 42.2±4.3 versus 40.7±2.2, and LXRβ, 247±39 versus 203±8, relative values, mean±SD of 3 determinations), which is consistent with unchanged expression of ABCA1 and G1 transporters in these cells.
oxLDL-Induced Foam Cell Formation Is Exaggerated in BMP-Enriched Cells
Another functional consequence of BMP accumulation was evaluated by foam cell formation assay. As expected, Nile red-positive cells were significantly increased after exposure to oxLDL compared with controls (oxLDL versus controls, +30%; P<0.0001; Figure 6A and 6B). Most importantly, Nile red staining was further enhanced in BMPenriched cells (oxLDL+18:1/18:1-PG versus controls, +48%; oxLDL+18:1/18:1-PG versus oxLDL; P=0.007), indicating that BMP accumulation contributes to foam cell formation. As control for BMP specificity, Nile red staining was measured in PG-enriched cells (supplemented with 16:0/16:0-PG), and no difference was observed with cells exposed to oxLDL only. 
Discussion
Our current study reveals not only the suppressive effects of BMP accumulation on cholesterol efflux in macrophages but also the underlying molecular mechanisms. Indeed, we demonstrated that BMP accumulation reduces the expression of key cholesterol regulatory genes, including ABCA1-, ABCG1-, SREBP2-, and SREBP2-dependent genes. We further connect the regulation of ABC transporters to the LXR pathway, with the putative involvement of LXR ligand oxysterols. Furthermore, we draw a possible link between BMP accumulation and atherogenesis through the exacerbated foam cell formation in BMP-enriched cells.
Our conclusions are established from studies based on the supplementation with 18:1/18:1-PG to induce BMP accumulation in RAW macrophages. Interesting studies from the Gruenberg team have been previously performed in BHK cells and fibroblasts using exogenous BMP provided by liposomes. By this approach, the authors were able to compare different BMP molecular species and BMP with different stereoconfigurations and demonstrated that both of these structural characteristics were relevant for BMP functions. 7 In our study, the aim was to evaluate the consequences of increased BMP closest to natural BMP. According to previous data, PG was converted into BMP with the natural sn-1:sn-1′ stereoconfiguration in RAW macrophages, 12 and we here show that molecular species composition of BMP was not significantly changed after supplementation with 18:1/18:1-PG. Furthermore, accumulated BMP was recovered in late endosomes. Importantly, we can reasonably conclude that BMP accumulation is responsible for the reported effects because key effects, such as cholesterol efflux and ABCG1 expression, were not reproduced under supplementation with 16:0/16:0-PG that accumulated in cells but was not converted to BMP.
Previous works including from our group have highlighted the involvement of BMP in the regulation of cholesterol transport, especially with respect to exit/retention in the endosome-lysosome compartment. [5] [6] [7] [8] Our present study examined the cholesterol distribution in downstream compartments, including PM and ER. We thereby showed that BMP accumulation compromised LDL-derived cholesterol transport to PM. Based on the repression of SREBP2 and HMG-coenzyme A reductase in BMP-enriched cells, we also concluded that BMP accumulation is associated with an increase in ER cholesterol content. In apparent contradiction, LDL uptake was not modified in BMP-enriched cells, whereas the expression of LDL receptor is known to be regulated by the SREBP2 pathway. Recent studies have reported that LDL receptor could be degraded by inducible degrader of the LDL receptor (an E3 ubiquitin ligase), whose expression is controlled by LXR. 21 Because LXRs are repressed in BMP-enriched cells, one possible mechanism is a less inducible degrader of the LDL receptor-dependent degradation of LDL receptor, which could compensate for its putative suppression by the SREBP2 pathway. Also surprising with respect to increased ER cholesterol is the fact that cholesterol esterification was not increased in BMP-enriched cells, suggesting that ER cholesterol accumulation would then specifically impact on SREBP2-and SREBP-dependent genes. It could be that these genes respond to smaller variation of ER cholesterol content compared with acetyl-coenzyme A acetyltransferase activity. Alternatively, it has been suggested that specific FC pools in ER could be involved for acetyl-coenzyme A acetyltransferase activation, 22 and this pool may not be modified in BMP-enriched cells.
Mechanisms responsible for altered distribution of cholesterol to ER and PM are quite difficult to investigate because pathways of intracellular cholesterol trafficking at the molecular level are poorly understood. 23 It is, however, assumed that the NP type C proteins NP type C1 and NP type C2 are involved in the normal egress of cholesterol out of late endosomes, 24, 25 and several studies have suggested functional interaction between BMP and NP type C proteins. 7, 24 Although it is generally accepted that ABCA1 functions in cholesterol efflux at the PM, it has been suggested that localization and trafficking of ABCA1 into intracellular compartments, including late endosomes, may play an important role in modulating ABCA1 transporter activity. [26] [27] [28] The possibility that BMP accumulation in late endosomes affects ABCA1 trafficking through this organelle is thus to investigate. Previously, we reported that anti-BMP antibody altered LDL-derived cholesterol distribution in RAW macrophages. 8 Further experiments have revealed cholesterol redistribution among PM-specific cholesterol pools (unpublished observations). Together with our present data, these observations support the hypothesis that endosomal BMP is important for normal targeting of cholesterol to functional pools.
One major functional consequence of BMP accumulation is the suppressive effects on both HDL and apoA1-stimulated cholesterol efflux, which correlated with the repression of ABCG1 and ABCA1 transporters. The contribution of oleoyl moieties in the downexpression of ABC transporters in BMPenriched cells (ie, supplemented with 18:1/18:1-PG) should be considered regarding that unsaturated fatty acids, including oleic acid, have been shown to repress these transporters 29, 30 or to be inactive. 31, 32 When exerting suppressive effects, oleic acid was supplied as a nonesterified fatty acid at relatively high concentrations (from 0.1 to 1 mmol/L), which is several orders of magnitude higher than in our experimental conditions (esterified oleate, 30 µmol/L PG). LXR data are also informative in this respect because BMP accumulation attenuated the expression of LXRs, whereas oleic acid was reported to have no effect. 29 All these observations weaken the possibility that oleic acid alone mediates the effects of 18:1/18:1-PG.
In contrast to BMP accumulation, antibody blocking BMP did not change the expression of cholesterol-regulating genes ABCA1, ABCG1, SREBP, and LXRs (not shown). Reduced cholesterol efflux by anti-BMP antibody may then result, as mentioned above, from cholesterol redistribution among PM-specific cholesterol pools not available to HDL. ABCA1 and ABCG1 transporter genes are well-known targets of LXRs, whose regulation depends on several parameters, including protein synthesis and activation by ligands. 33 Very little is known about the regulation of LXR expression. Our data indicate that both LXRα and LXRβ genes are induced after loading with native LDL. Because LDL-induced LXR expression was reduced by BMP-enriched cells, we propose that downregulation of LXRs contributes to the downregulation of ABCA1 and ABCG1 genes. This hypothesis is supported by the fact that overexpression of LXRα is correlated to increased expression of both ABCA1 and ABCG1 in RAW macrophages. 19 Deactivation of LXRs by a lack of ligand is another possible mechanism because the decreased cholesterol efflux in BMP-enriched cells was reversed in the presence of LXR activators. To further investigate LXR activation pathway, we attempted to measure the cellular content of 25-hydroxycholesterol and 27-hydroxycholesterol, 2 potent ligands of LXR receptors. 33 However, both 25-hydroxycholesterol and 27-hydroxycholesterol were detected at very low levels in control cells and were not increased on LDL loading, not supporting their involvement in LXR activation. 34 Another potent LXR activator is 24(S),25-epoxycholesterol, a unique oxysterol in that it is produced through a shunt of the mevalonate pathway for cholesterol. Several studies have shown that inhibition of 24(S),25-epoxycholesterol synthesis is correlated with ABCA1 downregulation, whereas stimulation induced upregulation. [35] [36] [37] Of specific interest, it was proposed that SREBP2 is required for the synthesis of 24(S),25epoxycholesterol. 38 Because we found that expressions of SREBP2 and HMG-coenzyme A reductase were decreased in BMP-enriched cells, one would expect a decrease in 24(S),25epoxycholesterol in these cells, which could lead to lower LXR activation and ABCA1 and ABCG1 downregulation. Further research in this area is certainly warranted and should provide better understanding of the role of endogenous oxysterols in the LXR/ABCA1-ABCG1 pathway in macrophages.
In conclusion, our findings shed some light on the still enigmatic late endosomal phospholipid BMP. We propose a functional link between endosomal BMP and the LXR/ABCA1/ ABCG1 pathway underlying the effects of BMP on the regulation of cholesterol homeostasis in macrophages (Figure 7) . Of pathophysiological relevance, we show that foam cell formation induced by oxLDL was exaggerated in BMP-enriched cells, supporting a role of BMP in atherogenesis. Figure 7 . Recapitulating scheme of the alterations induced by endosomal bis(monoacylglycero)phosphate (BMP) accumulation and putative connecting mechanisms. Low-density lipoprotein (LDL) particles carrying cholesterol ester (CE) are internalized through LDL receptor and reached late endosomes. In this compartment, CE hydrolase produces free cholesterol (FC) that can be transported to other intracellular membranes, such as plasma membrane (PM) or endoplasmic reticulum (ER). Incubation of cells with 18:1/18:1-phosphatidylglycerol (PG) liposomes induces an accumulation of 18:1/18:1-BMP into late endosomes because of the conversion of newly endocytosed PG (1) . BMP accumulation is correlated with FC redistribution: diminution of FC incorporation into PM (2) and increase of FC content in ER (3). ER-FC accumulation induces a suppression of sterol regulatory element-binding protein (SREBP) 2 and hydroxymethylglutaryl-coenzyme A reductase (HMGCoA) expression (4), which could in turn reduce the formation of liver-X receptor (LXR) activator 24(S),25-epoxycholesterol and thus ATP-binding cassette transporter (ABC) A1/ABCG1 expression (5) , leading to a decrease of FC efflux to high-density lipoprotein (HDL) and apolipoprotein A1 (apoA1; 6). LXR downregulation may be an additional mechanism to decrease ABCA1/ABCG1 expression (7) .
